Neutropenic Fever-Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 Pandemic.

Autor: Baus CJ; University of Wisconsin School of Pharmacy, Madison., Kelley B; University of Wisconsin School of Medicine and Public Health, Madison., Dow-Hillgartner E; University of Wisconsin School of Pharmacy, Madison.; University of Wisconsin Carbone Cancer Center, Madison., Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison.; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison., Schulz LT; University of Wisconsin School of Pharmacy, Madison., Lepak AJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison., LoConte NK; University of Wisconsin Carbone Cancer Center, Madison.; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.

Publikováno v: JAMA network open [JAMA Netw Open] 2023 Mar 01; Vol. 6 (3), pp. e234881. Date of Electronic Publication: 2023 Mar 01.

Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System.

Autor: Frei CR; South Texas Veterans Health Care System, San Antonio, TX, USA.; College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA., Le H; AstraZeneca US Medical Affairs, Gaithersburg, MD, USA., McHugh D; AstraZeneca US Medical Affairs, Gaithersburg, MD, USA., Ryan K; AstraZeneca US Medical Affairs, Gaithersburg, MD, USA., Jones X; South Texas Veterans Health Care System, San Antonio, TX, USA.; College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA., Galley S; South Texas Veterans Health Care System, San Antonio, TX, USA., Franklin K; South Texas Veterans Health Care System, San Antonio, TX, USA., Baus CJ; College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA., Tavera J; South Texas Veterans Health Care System, San Antonio, TX, USA., Janania-Martinez M; South Texas Veterans Health Care System, San Antonio, TX, USA., Gregorio D; South Texas Veterans Health Care System, San Antonio, TX, USA., Ananth S; South Texas Veterans Health Care System, San Antonio, TX, USA., Uribe R; South Texas Veterans Health Care System, San Antonio, TX, USA., Surapaneni P; South Texas Veterans Health Care System, San Antonio, TX, USA., Espinoza-Gutarra M; South Texas Veterans Health Care System, San Antonio, TX, USA., Song MM; South Texas Veterans Health Care System, San Antonio, TX, USA., Teng C; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, The University of South Carolina, Columbia, SC, USA., Obodozie-Ofoegbu OO; College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA., Nooruddin Z; South Texas Veterans Health Care System, San Antonio, TX, USA.; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1664-1673. Date of Electronic Publication: 2021 Feb 11.